The impact on health outcome measures of switching to generic medicines consequent to reference pricing: the case of olanzapine in New Zealand
INTRODUCTION: New Zealand's Pharmaceutical Management Agency (PHARMAC)
manages the list of medicines available for prescribing with government subsidy, within a …
manages the list of medicines available for prescribing with government subsidy, within a …
Reference pricing and health outcomes: Evaluating the impact of generic substitution in New Zealand
C Lessing - 2015 - researchspace.auckland.ac.nz
Background A fundamental predicament faced by healthcare policy makers is balancing
access to the most effective and oftentimes expensive medicines whilst containing total …
access to the most effective and oftentimes expensive medicines whilst containing total …